Stocks
GlaxoSmithKline (GSK) EV US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV, £ | ? | 83 846 820 000 | 83 846 820 000 | 154 583 640 000 | 165 189 660 000 | 164 649 999 996 | 66 658 000 000 | ||
| Changes by years, y/y, % | -7% | 0% | +84% | +7% | 0% | +11.1% | |||
GlaxoSmithKline. EV, £
GlaxoSmithKline. EV, changes, %
GlaxoSmithKline (GSK) EV US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV, £ | ? | 92 480 750 000 | 100 896 015 000 | 80 183 200 000 | 171 001 500 000 | 80 183 200 000 | 66 658 000 000 | |
| Changes by years, y/y, % | -42% | -36% | -9% | +7% | -9% | |||
| Changes by quarters, q/q, % | -43% | +9% | -21% | +113% | -53% | |||
